27 July 2023 - Patients are struggling to get hold of the new medicines they desperately need and ask what ...
3 July 2023 - From 2025, a systematic evaluation of clinical studies for new medicinal products and medical devices will ...
13 June 2023 - On 26 April, the EU Commission presented a proposal for the revision of pharmaceutical legislation in ...
5 December 2022 - National health technology assessments across Europe show differences in evidentiary requirements from assessments by the EMA, affecting ...
23 August 2022 - A new health technology regulation is due to be applied to help EU countries determine the effectiveness ...
17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...
26 May 2022 - The objective of the European Network for Health Technology Assessment (EUnetHTA) Joint Action 3 (JA3) was to ...
19 April 2022 - The establishment of health technology assessment has been an important topic in Europe for many years. ...
3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...
24 February 2022 - An interesting letter to the Editor of the BMJ from the Head of Drug Assessment at ...
20 February 2022 - For assessing cost effectiveness, health technology assessment organisations may use primary economic evaluations or systematic reviews of ...
1 February 2022 - On Dec 15, 2021, the EU adopted a new regulation to harmonise health technology assessment of new ...
28 January 2022 - This article aims at describing the most relevant elements of the drug development process in the paediatric ...
28 January 2022 - The European Network for Health Technology Assessment (EUnetHTA) was established in 2006. During its final project phase ...
13 December 2021 - Today, the Regulation on Health Technology Assessment, a deliverable of the EU Pharmaceutical Strategy, has been adopted. ...